Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Pertuzumab
Related studies linked through entity extraction aliases.
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Pertuzumab Safety in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
- Status
- COMPLETED
- Phase
- PHASE3